News25/Ratings6
Price$37.52+13.85 (+58.51%)
2026-05-212026-08-25
News · 26 weeks63+29%
2026-03-012026-08-23
Mix2190d
- Other8(38%)
- Insider6(29%)
- SEC Filings4(19%)
- Earnings2(10%)
- Analyst1(5%)
Latest news
25 items- INSIDERSVP, Chief Growth Officer Misencik Tiffani sold $354,593 worth of shares (8,850 units at $40.07), decreasing direct ownership by 7% to 123,723 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- PRMarpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer ClientsExpanded agreement builds on PHCS network access with pre- and post-payment integrity capabilities spanning the claims lifecycle Claritev Corporation (NYSE:CTEV), a healthcare technology, data, and insights company, today announced that Marpai, Inc. (OTCQX:MRAI) has expanded its relationship with Claritev to bring comprehensive pre- and post-payment integrity capabilities to the health plans and claims it administers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260817677350/en/ Marpai currently uses Claritev’s PHCS® Network to provide access to healthcare providers and negotiated rates outside its clients’ primary networks.
- INSIDERSVP, Chief Strategy Officer Mintz William B. sold $288,677 worth of shares (8,431 units at $34.24), decreasing direct ownership by 11% to 71,195 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERSVP, Chief Strategy Officer Mintz William B. covered exercise/tax liability with 3,622 shares, decreasing direct ownership by 4% to 79,626 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDEREVP&CFO Garis Douglas Michael covered exercise/tax liability with 11,711 shares, decreasing direct ownership by 6% to 194,441 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- SECSEC Form 10-Q filed by Claritev Corporation10-Q - Claritev Corp (0001793229) (Filer)
- SECClaritev Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Claritev Corp (0001793229) (Filer)
- PRClaritev Corporation Reports Second Quarter 2026 ResultsQ2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025 Net Loss of $59.2 million Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025 (Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 2025) Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the second quarter ended June 30, 2026. "Claritev once again demonstrated the strength of our vision and strategy in the second quarter of 2026, delivering financial results above expectations with solid execution across the company. We are one year in
- PRClaritev Corporation Announces Participation in Canaccord Genuity 46th Annual Growth ConferenceClaritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will participate in the Canaccord Genuity 46th Annual Growth Conference, being held in Boston, including a fireside chat on Tuesday, August 11, 2026, at 10:00am ET. A live webcast and audio archive of the event will be available through the investor relations section of Claritev’s website at https://investors.claritev.com/news-events/events. About Claritev Claritev is a healthcare technology, data, and insights company focused on delivering affordability,
- PRClaritev Demonstrates Market Leadership as Federal No Surprises Act Disputes Reach Record LevelsNew CMS data shows Claritev led all non-payer organizations in federal IDR volume while delivering outcomes above industry averages Claritev achieved a 20% IDR success rate versus 12% industrywide, increasing to 24% versus 15% in the fourth quarter Claritev ranked as the market-leading independent non-payer IDR administrator, with volumes exceeded only by the nation’s largest health insurers Claritev Corporation (NYSE:CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that, according to newly released 2025 data from the Centers for Medicare & Medicaid Services (CMS), the Company hand
- PRClaritev™ and SAVVI Financial® Collaborate to Deliver the Next Generation of Healthcare Benefit Decision SupportNew solution combines claims-informed intelligence with AI-powered financial guidance to help employees make smarter benefits decisionsMCLEAN, Va. and WALTHAM, Mass., July 28, 2026 /PRNewswire/ -- Claritev Corporation (NYSE:CTEV), a healthcare technology, data, and insights company, and SAVVI Financial, a provider of workplace financial guidance, today announced Claritev Benefit Decision Support, a new solution that helps employers deliver more personalized benefits guidance while empowering employees to make better-informed choices about their healthcare coverage and financial priorities. Many benefit decision support tools still rely on lengthy employee questionnaires, generic assumptions,
- PRClaritev Adopts CodeTogether's AITrax to Bring Greater Measurement and Accountability to AI-Assisted DevelopmentClaritev will use CodeTogether's AITrax to help measure adoption, cost, quality, and value across its enterprise AI-assisted software development initiatives. MCLEAN, Va. and WILMINGTON, Del., July 21, 2026 /PRNewswire/ -- Claritev Corporation (NYSE:CTEV), a healthcare technology, data, and insights company focused on delivering affordability, transparency, and quality across the healthcare system, today announced it will use CodeTogether's AITrax to gain greater visibility into AI-assisted software development across its engineering organization. As AI-assisted development beco
- PRSun Life U.S. and Claritev work to boost efficiency of supplemental health benefitsConnected claims technology helps accelerate benefit payments for critical illness, accident, and hospital indemnity coverageWELLESLEY, Mass. and MCLEAN, Va., July 16, 2026 /PRNewswire/ -- Sun Life U.S., a leading provider of employee and government benefits, and Claritev, a healthcare technology, data and insights company, are working together to bring more efficiency to supplemental health coverage offered by self-funded employers. Claritev's machine-learning technology helps find diagnosis connections between employees' medical claims and supplemental health coverages – which include critical illness, accident and hospital indemnity – to help covered employees access the benefits they are
- PRClaritev Corporation Announces Second Quarter 2026 Earnings Conference CallClaritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its second quarter fiscal year 2026 financial results prior to market open on Friday, August 7, 2026, and hold a conference call at 8:00 am Eastern Time.A live webcast of the conference call can be accessed through the Investor Relations section of the Company’s website at investors.claritev.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. The earnings press release and supplemental slide deck wi
- PRClaritev Rises to Leader Ranking in Everest Group's 2026 Pre-Payment Integrity Solutions PEAK Matrix® AssessmentRecognition underscores the expansion of Claritev’s capabilities and company vision for connected payment integrity, responsible AI, and next-generation payment accuracy solutions Claritev Corporation (NYSE:CTEV), a technology, data, and insights company focused on making healthcare more affordable and transparent, today announced it has been recognized as a Leader in the Everest Group Pre-payment Integrity Solutions PEAK Matrix® Assessment 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260709267133/en/ The recognition and ascent into the Leader category reflects Claritev's longstanding history and continued investment i
- SECClaritev Corporation filed SEC Form 8-K: Other Events8-K - Claritev Corp (0001793229) (Filer)
- INSIDERSVP, Chief Accounting Officer Albinson Brock was granted 3,649 shares, increasing direct ownership by 12% to 33,842 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- PRClaritev Corporation Announces Participation in Truist Securities Healthcare Disruptors & Digital Health ConferenceClaritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference, including a panel discussion titled "The Data Before the AI: Building the Foundation for Scalable Healthcare Intelligence" with Michael Kim, Chief Digital Officer, on Wednesday, June 24, 2026, at 1:00pm ET. About Claritev Claritev is a healthcare technology, data, and insights company focused on delivering affordability, transparency, and quality across the U.S. healt
- SECClaritev Corporation filed SEC Form 8-K: Regulation FD Disclosure8-K - Claritev Corp (0001793229) (Filer)
- INSIDERSVP, Chief People Officer Carol Nutter bought $24,856 worth of shares (875 units at $28.41), increasing direct ownership by 2% to 46,941 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- ANALYSTCanaccord Genuity initiated coverage on Claritev with a new price targetCanaccord Genuity initiated coverage of Claritev with a rating of Buy and set a new price target of $32.00
- INSIDEREVP, Chief Digital Officer Kim Michael bought $49,950 worth of shares (3,000 units at $16.65), increasing direct ownership by 2% to 185,878 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERDirector Prince John Michael bought $160,000 worth of shares (10,000 units at $16.00), increasing direct ownership by 46% to 31,662 units (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- INSIDERPres., CEO & Executive Chair Dalton Travis bought $258,638 worth of shares (20,920 units at $12.36) (SEC Form 4)4 - Claritev Corp (0001793229) (Issuer)
- SECClaritev Corporation filed SEC Form 8-K: Regulation FD Disclosure8-K - Claritev Corp (0001793229) (Filer)
CTEV FAQ
6 questionsWhere does CTEV stock trade?
Claritev Corporation (CTEV) is listed on NYSE.What sector and industry is CTEV in?
Claritev Corporation operates in the Real Estate sector.When did Claritev Corporation go public?
Claritev Corporation (CTEV) completed its IPO in 2020.What are analysts saying about CTEV?
Claritev Corporation has had 6 recent analyst actions on file. The most recent action was from Canaccord Genuity: Buy with a $3200.00 price target on 2026-05-29. Recent price targets range from $2800.00 to $4400.00.What companies are similar to CTEV?
Notable peers in the same industry include V (Visa Inc.), MA (Mastercard Incorporated), BABA (Alibaba Group Holding Limited), UBER (Uber Technologies Inc.), ACN (Accenture plc). Compare CTEV side-by-side with any of them on Quantisnow.How can I track CTEV on Quantisnow?
Quantisnow aggregates Claritev Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CTEV to receive live email and push alerts on every new disclosure.